← FDA Drug Approvals (Drugs@FDA)

ATOVAQUONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2018-09-11

Drug application

FDA Application #

ANDA209105

Application type

Abbreviated New Drug Application (Generic)

Brand name

ATOVAQUONE

Generic name

Atovaquone

Active ingredients

ATOVAQUONE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

LUPIN

First approval

2018-09-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown